SEC Form 4 · accession 0001274644-16-000124
Ocera Therapeutics, Inc. · OCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Powell
Director
Period of report
Jul 11, 2016
Accepted (ET)
Jul 13, 2016 · 8:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001274644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 11, 2016 | M | 11,969 | $1.26 | A | 11,969 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.26 | Jul 11, 2016 | M | 11,969 | D | — | Jul 24, 2016 | Common Stock | 11,969 | 0 | D |
Explanation of responses
- F1This option is fully vested.